Home / Import refusals / AEK-4141301-2/11/1

FDA Import Refusal AEK-4141301-2/11/1 — Novartis Pharma Produktions GmbH

Novartis Pharma Produktions GmbH — FEI 3000978864

The FDA refused shipment AEK-4141301-2/11/1 from Novartis Pharma Produktions GmbH (Germany) on November 30, 2023. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 30, 2023
Country
Germany
Product Category
Drugs and Biologics
Product Code
61PCB26 METFORMIN (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1268304 (VAI Thu Jul 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108037 (NAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1015619 (NAI Fri May 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934282 (NAI Thu Jun 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 840743 (NAI Mon Jun 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-8099523-5/20002/1 (Fri May 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5318555-1/11/1 (Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4276505-9/21/1 (Fri Nov 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5660756-5/31/1 (Fri Sep 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5180971-1/11/1 (Fri May 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources